2. Academic Validation
  3. Discovery of Spiro[chromane-2,4'-piperidine] Derivatives as Irreversible Inhibitors of SARS-CoV-2 Papain-like Protease

Discovery of Spiro[chromane-2,4'-piperidine] Derivatives as Irreversible Inhibitors of SARS-CoV-2 Papain-like Protease

  • J Med Chem. 2026 Feb 12;69(3):3588-3608. doi: 10.1021/acs.jmedchem.5c03704.
Qiangqiang Wei 1,  Ashley J Taylor 1,  Nagaraju Miriyala 1,  Mahesh A Barmade 1,  Zachary O Gentry 1,  Jordan Anderson-Daniels 2,  Kevin B Teuscher 1,  Mackenzie M Crow 1,  Chideraa Apakama 1,  Taylor M South 1,  Tyson A Rietz 1,  Kangsa Amporndanai 1,  Jason Phan 1,  John L Sensintaffar 1,  Mark Denison 2,  Taekyu Lee 1,  Stephen W Fesik 1 3 4
Affiliations

Affiliations

  • 1 Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146, United States.
  • 2 Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States.
  • 3 Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-6600, United States.
  • 4 Department of Chemistry, Vanderbilt University, Nashville, Tennessee 37235, United States.
PMID: 41629155 DOI: 10.1021/acs.jmedchem.5c03704
Abstract

The papain-like protease (PLPro) plays a key role in SARS-CoV-2 replication and represents a promising target for the development of new Antiviral therapies. Previous efforts to develop fragment-derived inhibitors of PLPro led to the identification of a novel class of spiro[chromane-2,4'-piperidin]-4-one inhibitors exemplified by lead compound 7. High-resolution covalent cocrystal structures and molecular dynamics simulations were utilized to guide the development of a series of low-nanomolar irreversible PLPro inhibitors, with lead compound 45 demonstrating strong enzymatic inhibition (IC50 = 0.059 μM at T = 60 min) and Antiviral activity in A549 cells (EC50 = 2.1 μM at 48 hpi). This novel class of inhibitors represents a promising avenue for the development of therapeutics to overcome the potential of drug-resistant viral strains and future coronavirus outbreaks.

Figures
Products